- Public Comps
- Skinkandy
Skinkandy Valuation Multiples
Discover revenue and EBITDA valuation multiples for Skinkandy and similar public comparables like MTI Ltd., Cosmax BTI, IBJ Inc., Nu Skin and more.
Skinkandy Overview
About Skinkandy
Skinkandy Ltd is engaged in body piercing and jewellery retailing business. The company generates revenue from providing body piercing services and the sale of jewellery products.
Founded
2010
HQ

Employees
N/A
Website
Financials (LTM)
EV
$217M
Valuation Multiples
Start free trialSkinkandy Financials
Skinkandy reported last 12-month revenue of $67M and EBITDA of $18M.
In the same LTM period, Skinkandy generated $60M in gross profit, $18M in EBITDA, and $1M in net income.
Skinkandy P&L
In the most recent fiscal year, Skinkandy reported revenue of $51M and EBITDA of $14M.
Skinkandy is profitable as of last fiscal year, with gross margin of 90%, EBITDA margin of 28%, and net margin of 11%.
Financial data powered by Morningstar, Inc.
Skinkandy Stock Performance
Skinkandy has current market cap of $207M, and enterprise value of $217M.
Skinkandy's stock price is $1.85.
Skinkandy has an EPS (earnings per share) of $0.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $217M | $207M | -0.2% | - | 4.2% | - | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSkinkandy Valuation Multiples
Skinkandy trades at 3.2x EV/Revenue multiple, and 11.7x EV/EBITDA.
Skinkandy Financial Valuation Multiples
As of September 1, 2026, Skinkandy has market cap of $207M and EV of $217M.
Skinkandy has a P/E ratio of 139.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Skinkandy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Skinkandy Margins & Growth Rates
Skinkandy grew revenue by 25% and EBITDA by 25% in the last fiscal year.
In the most recent fiscal year, Skinkandy reported gross margin of 90%, EBITDA margin of 28%, and net margin of 11%.
Skinkandy Margins
Skinkandy Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Skinkandy Operational KPIs
Skinkandy's Rule of 40 is 52% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Skinkandy's Rule of X is 88% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Skinkandy Competitors
Skinkandy competitors include MTI Ltd., Cosmax BTI, IBJ Inc., Nu Skin, Warpaint London, Waldencast, Acme United, CLIO Cosmetics, Midsona and Weight Watchers.
Most Skinkandy public comparables operate across Personal Services and Health & Beauty.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.8x | 0.8x | 4.0x | 5.4x | |||
| 1.1x | - | 9.5x | - | |||
| 1.9x | 1.5x | 9.3x | - | |||
| 0.2x | 0.2x | 1.1x | - | |||
| 1.6x | 1.6x | 7.7x | 7.4x | |||
| 1.2x | 1.2x | (1.9x) | 14.2x | |||
| 1.4x | 1.3x | 13.0x | - | |||
| 0.2x | - | 5.0x | - | |||
This data is available for Pro users. Sign up to see all Skinkandy competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Skinkandy
| When was Skinkandy founded? | Skinkandy was founded in 2010. |
| Where is Skinkandy headquartered? | Skinkandy is headquartered in Australia. |
| Who is the CEO of Skinkandy? | Skinkandy's CEO is Mark Oliphant. |
| Is Skinkandy publicly listed? | Yes, Skinkandy is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Skinkandy? | Skinkandy trades under SK1 ticker. |
| When did Skinkandy go public? | Skinkandy went public in 2026. |
| Who are competitors of Skinkandy? | Skinkandy main competitors include MTI Ltd., Cosmax BTI, IBJ Inc., Nu Skin, Warpaint London, Waldencast, Acme United, CLIO Cosmetics, Midsona, Weight Watchers. |
| What is the current market cap of Skinkandy? | Skinkandy's current market cap is $207M. |
| What is the current revenue of Skinkandy? | Skinkandy's last 12 months revenue is $67M. |
| What is the current revenue growth of Skinkandy? | Skinkandy revenue growth (NTM/LTM) is 22%. |
| What is the current EV/Revenue multiple of Skinkandy? | Current revenue multiple of Skinkandy is 3.2x. |
| What is the current EBITDA of Skinkandy? | Skinkandy's last 12 months EBITDA is $18M. |
| What is Skinkandy's EBITDA margin? | Skinkandy's last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Skinkandy? | Current EBITDA multiple of Skinkandy is 11.7x. |
| What is the current FCF of Skinkandy? | Skinkandy's last 12 months FCF is $4M. |
| What is Skinkandy's FCF margin? | Skinkandy's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Skinkandy? | Current FCF multiple of Skinkandy is 58.2x. |
| How many companies Skinkandy has acquired to date? | Skinkandy hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Skinkandy has invested to date? | Skinkandy hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Skinkandy
Lists including Skinkandy
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




